The Latest in Stroke Risk Reduction Strategies: Are Your Patients Protected?

Learn about the role GLP-1 RAs play in stroke risk reduction, especially among patients with type 2 diabetes. Expert faculty review the latest evidence and strategies for individualizing care plans to address patients’ stroke risk through ClinicalThought commentaries, an on-demand webcast with accompanying slides, and a downloadable clinical resource.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Novo Nordisk.

Novo Nordisk